 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 1280
S.P. 432 In Senate, April 4, 2017
An Act  Regarding Generic Drug Pricing
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
HEATHER  J.R. PRIEST
Secretary of the Senate
Presented by Senator JACKSON of  Aroostook.
Cosponsored by Representative GATTINE of Westbrook and
Senators: BELLOWS of Kennebec, CARSON  of Cumberland, DAVIS of Piscataquis,  
SAVIELLO of Franklin, VITELLI of Sagadahoc, Representatives: LAWRENCE  of South  
Berwick, MASTRACCIO of Sanford.

 
 Page 1 - 128LR1232(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  32 MRSA §13702 -A, sub -§12-A is enacted to read:  2 
12-A.  Eligible product developer.  "Eligible product developer" means a person 3 
that seeks to develop an application for the approval of a drug under the Federal Food, 4 
Drug, and Cosmetic Act, Section 505(b) or 505(j) or the licensing of a biological product 5 
under the federal Public Health Service Act, Section 351.  6 
Sec. 2.  32 MRSA §13742 -A, sub -§1, ¶¶C and D, as enacted by PL 2007, c. 7 
402, Pt. DD, §19, are amended to read:  8 
C.  Engaging in unprofessional conduct by violating any standard of professional 9 
behavior, including but not limited to a breach of confidentiality of health care 10 
information pursuant to state law, that has been establishe d in the practice for which 11 
the licensee is licensed; or 12 
D.  Engaging in false, misleading or deceptive advertising .; or 13 
Sec. 3.  32 MRSA §13742 -A, sub -§1, ¶E is enacted to read:  14 
E.  Failing to comply with section 13800.  15 
Sec. 4.  32 MRSA §13742 -A, sub -§4 is enacted to read:  16 
4.  Injunction.  Notwithstanding any other provision of law, the Attorney General 17 
may seek injunctive relief against a person who violates subsection 1, paragraph E.  18 
Sec. 5.  32 MRSA §13800 is enacted to read:  19 
§13800.  Access to distribu ted drugs  20 
A drug distributed in this State must be made available for sale in this State, at fair 21 
market price and without any restriction that delays access, to an eligible product 22 
developer.  23 
SUMMARY  24 
This bill amends the Maine Pharmacy Act to require that  a drug distributed in this 25 
State must be made available for sale in this State to a person seeking to develop an 26 
application for the approval of the drug under the Federal Food, Drug, and Cosmetic Act 27 
or the licensing of a biological product under the fed eral Public Health Service Act.  It 28 
establishes disciplinary actions for noncompliance.  29 
 
